Category Archives: Europe

Pricing and Reimbursement in Europe: Where Does Innovation Fit?

By Leela Barham. It was recently said, in reference to the UK’s Value-Based Assessment(VBA) program, that innovation had not been “tried and tested in the pricing context”, which explains the loss of the “innovation” criteria from the proposals formerly known as Value-Based Pricing (VBP). This prompted me to think about just how has innovation been […]
Also posted in Global, Guest Blog, pricing, R&D | Tagged , , , , , | Leave a comment

UK: Lord Saatchi's Innovation Bill Divides Healthcare Community

By Leela Barham. Few would argue with the desirability of innovation — something new, something that delivers value. And innovation in pharmaceuticals is a range from a more convenient way for patients to take a medicine, to treating a disease that couldn’t be treated before. Pretty much everyone will agree that not only do they […]
Also posted in Global, Guest Blog, Regulatory | Tagged , , | Leave a comment

Online Patient Library Set for European Launch

By Philip Ward. The new Internet Library from the European Patients’ Academy (EUPATI) will come online towards the end of 2015, and will be available in seven European languages (English, French, Spanish, Italian, German, Polish and Russian), project director Jan Geissler revealed at last week’s workshop held in Warsaw, Poland, and organized by EUPATI.
Also posted in healthcare, Patient Communication, patient education | Tagged , , , , , | Leave a comment

Six Steps to Better Cancer Care in Europe

A  report published yesterday provides recommendations for combating the “significant inequalities” affecting access to quality cancer care in Europe.
Also posted in healthcare | Tagged , , , | Leave a comment

"Work to Be Done" on EU Clinical Trials Regulation, Says Industry

The European Parliament yesterday voted towards the adoption of the new Clinical Trials Regulation, which removes the legal framework for pharma to not publish its data by stating that information from  trial study reports should not be considered commercially confidential.
Also posted in Global, Regulatory | Tagged , , , , | Leave a comment
  • Categories

  • Meta